M Bellet

Dual endothelin antagonist aprocitentan for resistant hypertension (PRECISION): a multicentre, blinded, randomised, parallel-group, phase 3 trial

Markus P. Schlaich, M Bellet, Michael A. Weber et al. · The Lancet · 2022 · 206 citations · Full text

Molecular Pharmacology, Hypertension, Resistant Hypertension +9

Systemic hypertension after cardiac transplantation: Effect of cyclosporine on the renin-angiotensin-aldosterone system

M Bellet, P Sassano, Philippe Léger et al. · The American Journal of Cardiology · 1985 · 139 citations

Hypertension, Transplantation, Cardiovascular Disease +9

Randomized Dose-Response Study of the New Dual Endothelin Receptor Antagonist Aprocitentan in Hypertension

Parisa Danaietash, Bruno Flamion, Joël Ménard et al. · Hypertension · 2020 · 88 citations · Full text

CENTRAL CARDIOVASCULAR EFFECTS OF NARCOTIC ANALGESICS AND ENKEPHALINS IN RATS

M Bellet, J. L. Elghozi, P Meyer et al. · British Journal of Pharmacology · 1980 · 73 citations · Full text

Inheritance of abnormal erythrocyte cation transport in essential hypertension.

Philippe Meyer, Ricardo P. Garay, Corinne Nazaret et al. · BMJ · 1981 · 64 citations · Full text

Hypertonicity, Hypertension, Electrolyte Disorder +15